- Investing Ideas
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
18
Companies which are more than 50% undervalued based on analyst price target.
18 companies
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.75
7D
5.9%
1Y
22.0%
Eupraxia Pharmaceuticals
Market Cap: CA$618.0m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$9.09
7D
-2.0%
1Y
20.7%
Verano Holdings
Market Cap: CA$610.7m
Engages in the cannabis business in the United States.
VRNO
CA$8.40
7D
1.9%
1Y
97.6%
Cresco Labs
Market Cap: CA$490.5m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.14
7D
2.7%
1Y
32.6%
Spectral Medical
Market Cap: CA$396.1m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.33
7D
-2.2%
1Y
56.5%
TerrAscend
Market Cap: CA$302.2m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.86
7D
2.4%
1Y
68.6%
High Tide
Market Cap: CA$274.2m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.10
7D
-3.1%
1Y
-5.5%
Aurora Cannabis
Market Cap: CA$239.1m
Engages in the production, distribution, and sale of cannabis products in Canada and internationally.
ACB
CA$3.80
7D
-1.8%
1Y
-39.4%
Organigram Global
Market Cap: CA$192.9m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.27
7D
-9.0%
1Y
-37.1%
Cardiol Therapeutics
Market Cap: CA$166.0m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.50
7D
-2.0%
1Y
-17.1%
HLS Therapeutics
Market Cap: CA$134.8m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.23
7D
-1.6%
1Y
-13.5%
Decibel Cannabis
Market Cap: CA$63.5m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
0%
1Y
27.8%
Vext Science
Market Cap: CA$57.0m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.25
7D
8.7%
1Y
42.9%
Sernova Biotherapeutics
Market Cap: CA$47.2m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.10
7D
-22.2%
1Y
-34.4%
Optimi Health
Market Cap: CA$36.5m
Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
OPTI
CA$6.56
7D
-3.8%
1Y
41.1%
Medicenna Therapeutics
Market Cap: CA$34.2m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.37
7D
-3.9%
1Y
-55.4%
Rubicon Organics
Market Cap: CA$30.4m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.45
7D
-1.1%
1Y
-7.3%
Delivra Health Brands
Market Cap: CA$3.3m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.10
7D
-9.1%
1Y
-58.3%